Development
NP Life Sciences Health Industry Group Inc.
NPLS
$0.0539
-$0.0962-64.09%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -57.32% | 614.00% | -- | 31.43% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -57.32% | 614.00% | -- | 31.43% | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -57.32% | 614.00% | -- | 31.43% | -- |
| SG&A Expenses | 18.53% | 156.83% | -7.40% | 988.89% | 123.08% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 18.53% | 156.83% | -7.40% | 988.89% | 123.08% |
| Operating Income | -592.59% | 6,390.91% | 103.86% | -48.61% | 74.04% |
| Income Before Tax | -598.15% | 6,372.73% | 103.86% | -48.61% | 74.04% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -598.15% | 6,372.73% | 103.86% | -48.61% | 74.04% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -598.15% | 6,372.73% | 103.86% | -48.61% | 74.04% |
| EBIT | -592.59% | 6,390.91% | 103.86% | -48.61% | 74.04% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -800.00% | -- | 100.00% | -50.00% | 80.00% |
| Normalized Basic EPS | -400.00% | -- | 100.00% | -60.00% | 66.67% |
| EPS Diluted | -800.00% | -- | 100.00% | -50.00% | 80.00% |
| Normalized Diluted EPS | -400.00% | -- | 100.00% | -60.00% | 66.67% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |